Setmelanotide
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
Rhythm · Phase 1/2 · Completed · Enrollment 99
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setmelanotide Once Daily | Obesity or overweight | n/r | n/r | n/r | n/r |
| Setmelanotide Split Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |